Rapid antibody test for diagnosing fragile X syndrome: A validation of the technique

Rob Willemsen; Arie Smits; Serieta Mohkamsing; Hetty Van Beerendonk; Anton De Haan; Bert De Vries; Ans Van Den Ouweland; Erik Sistermans; Hans Galjaard; Ben A. Oostra

doi:10.1007/s004390050363

Rapid antibody test for diagnosing fragile X syndrome: A validation of the technique

Rob Willemsen, Arie Smits, Serieta Mohkamsing, Hetty Van Beerendonk, Anton De Haan, Bert De Vries, Ans Van Den Ouweland, Erik Sistermans, Hans Galjaard, Ben A. Oostra^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

To date, the identification of patients and carriers of the fragile X syndrome has been carried out by DNA analysis by means of the polymerase chain reaction and Southern blot analysis. This direct DNA analysis allows both the size of the CGG repeat and methylation status of the FMR1 gene to be determined. We have recently presented a rapid antibody test on blood smears based on the presence of FMRP, the protein product of the FMR1 gene, in lymphocytes from normal individuals and the absence of FMRP in lymphocytes from patients. Here, we have tested the diagnostic value of this new technique by studying FMRP expression in 173 blood smears from normal individuals and fragile X patients. The diagnostic power of the antibody test is 'perfect' for males, whereas the results are less specific for females.

Original language	English
Pages (from-to)	308-311
Number of pages	4
Journal	Human Genetics
Volume	99
Issue number	3
DOIs	https://doi.org/10.1007/s004390050363
Publication status	Published - Mar 1997

Access to Document

10.1007/s004390050363

Cite this

@article{1683d1cadfcc43e1bf9a03e6659c1e85,

title = "Rapid antibody test for diagnosing fragile X syndrome: A validation of the technique",

abstract = "To date, the identification of patients and carriers of the fragile X syndrome has been carried out by DNA analysis by means of the polymerase chain reaction and Southern blot analysis. This direct DNA analysis allows both the size of the CGG repeat and methylation status of the FMR1 gene to be determined. We have recently presented a rapid antibody test on blood smears based on the presence of FMRP, the protein product of the FMR1 gene, in lymphocytes from normal individuals and the absence of FMRP in lymphocytes from patients. Here, we have tested the diagnostic value of this new technique by studying FMRP expression in 173 blood smears from normal individuals and fragile X patients. The diagnostic power of the antibody test is 'perfect' for males, whereas the results are less specific for females.",

author = "Rob Willemsen and Arie Smits and Serieta Mohkamsing and {Van Beerendonk}, Hetty and {De Haan}, Anton and {De Vries}, Bert and {Van Den Ouweland}, Ans and Erik Sistermans and Hans Galjaard and Oostra, {Ben A.}",

year = "1997",

month = mar,

doi = "10.1007/s004390050363",

language = "English",

volume = "99",

pages = "308--311",

journal = "Human Genetics",

issn = "0340-6717",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Rapid antibody test for diagnosing fragile X syndrome

T2 - A validation of the technique

AU - Willemsen, Rob

AU - Smits, Arie

AU - Mohkamsing, Serieta

AU - Van Beerendonk, Hetty

AU - De Haan, Anton

AU - De Vries, Bert

AU - Van Den Ouweland, Ans

AU - Sistermans, Erik

AU - Galjaard, Hans

AU - Oostra, Ben A.

PY - 1997/3

Y1 - 1997/3

N2 - To date, the identification of patients and carriers of the fragile X syndrome has been carried out by DNA analysis by means of the polymerase chain reaction and Southern blot analysis. This direct DNA analysis allows both the size of the CGG repeat and methylation status of the FMR1 gene to be determined. We have recently presented a rapid antibody test on blood smears based on the presence of FMRP, the protein product of the FMR1 gene, in lymphocytes from normal individuals and the absence of FMRP in lymphocytes from patients. Here, we have tested the diagnostic value of this new technique by studying FMRP expression in 173 blood smears from normal individuals and fragile X patients. The diagnostic power of the antibody test is 'perfect' for males, whereas the results are less specific for females.

AB - To date, the identification of patients and carriers of the fragile X syndrome has been carried out by DNA analysis by means of the polymerase chain reaction and Southern blot analysis. This direct DNA analysis allows both the size of the CGG repeat and methylation status of the FMR1 gene to be determined. We have recently presented a rapid antibody test on blood smears based on the presence of FMRP, the protein product of the FMR1 gene, in lymphocytes from normal individuals and the absence of FMRP in lymphocytes from patients. Here, we have tested the diagnostic value of this new technique by studying FMRP expression in 173 blood smears from normal individuals and fragile X patients. The diagnostic power of the antibody test is 'perfect' for males, whereas the results are less specific for females.

UR - http://www.scopus.com/inward/record.url?scp=17544386437&partnerID=8YFLogxK

U2 - 10.1007/s004390050363

DO - 10.1007/s004390050363

M3 - Article

C2 - 9050914

AN - SCOPUS:17544386437

VL - 99

SP - 308

EP - 311

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 3

ER -

Rapid antibody test for diagnosing fragile X syndrome: A validation of the technique

Abstract

Access to Document

Other files and links

Cite this